Wall Street Analysts Are Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Iterum Therapeutics (ITRMResearch Report), Aslan Pharmaceuticals (ASLNResearch Report) and AVEO Pharma (AVEOResearch Report) with bullish sentiments.

Iterum Therapeutics (ITRM)

H.C. Wainwright analyst Ed Arce maintained a Buy rating on Iterum Therapeutics today and set a price target of $17.00. The company’s shares closed last Monday at $2.41, close to its 52-week low of $2.08.

According to TipRanks.com, Arce is a 4-star analyst with an average return of 6.3% and a 35.3% success rate. Arce covers the Healthcare sector, focusing on stocks such as Entasis Therapeutics Holdings, Madrigal Pharmaceuticals, and Conatus Pharmaceuticals.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Iterum Therapeutics with a $18.50 average price target, implying a 683.9% upside from current levels. In a report released yesterday, Needham also maintained a Buy rating on the stock with a $20.00 price target.

See today’s analyst top recommended stocks >>

Aslan Pharmaceuticals (ASLN)

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Aslan Pharmaceuticals, with a price target of $2.00. The company’s shares closed last Monday at $0.37, close to its 52-week low of $0.36.

According to TipRanks.com, Chen is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -26.8% and a 17.8% success rate. Chen covers the Healthcare sector, focusing on stocks such as HTG Molecular Diagnostics, EyePoint Pharmaceuticals, and Stealth Biotherapeutics.

Currently, the analyst consensus on Aslan Pharmaceuticals is a Moderate Buy with an average price target of $1.50.

AVEO Pharma (AVEO)

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on AVEO Pharma today and set a price target of $1.75. The company’s shares closed last Monday at $0.71, close to its 52-week low of $0.47.

According to TipRanks.com, Ramakanth has 0 stars on 0-5 star ranking scale with an average return of -8.8% and a 31.9% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as ThermoGenesis Holdings, IntelGenx Technologies, and Cellectar Biosciences.

AVEO Pharma has an analyst consensus of Moderate Buy, with a price target consensus of $2.20.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.